About this service
Cell-based approaches, including MSC-related research, are being investigated for musculoskeletal tissue responses and joint conditions.
Biologic approaches
Depending on the service, the approaches discussed may include platelet-rich plasma (PRP), exosome-derived products, or cell-based methods. These are distinct technologies with different preparation methods, evidence, and regulatory status.
Options and pricing
| Service | Treatment option |
|---|---|
| Joint injections — Cellular | 1 injection |
Important: PRP, exosome-derived products, and cellular interventions are not interchangeable. Clinical evidence, risks, and FDA regulatory status differ. The FDA has not approved exosome products for these applications; discuss the specific proposed treatment and its status with your clinician.